Corporate Banner
Satellite Banner
Pharma Outsourcing
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

GCT Selects CRO Starter Kit™ PSA Platform by Flex Databases

Published: Thursday, February 13, 2014
Last Updated: Thursday, February 13, 2014
Bookmark and Share
CRO Starter Kit™ provide increased efficiency and speed in running clinical research projects.

Flex Databases has announced that Global Clinical Trials, LLC (GCT) has selected Flex CRO Starter Kit™ as its business automation platform.

GCT is a regional Contract Research Organization (CRO), established in 2001 and headquartered in Princeton, NJ with full-service clinical operations in Russia and Eastern Europe.

"From the very foundation of the company GCT had a clear growth strategy", says Dr. Eugene Selivra, CEO of GCT. "We developed organically, step by step, basing our growth on the experience and knowledge of the management team and efficient business processes. But we always knew a time would come when we would need a software platform to help us handle the increased complexity, size and number of projects. We explored the market in search of a system that would become a core application, driving all of our day-to-day activities. The CRO Starter Kit™ platform became a perfect match for our needs. It has vital tools for a CRO today, such as budget management, eTMF, a Learning Management System, timesheets and more. But above all, CRO Starter Kit™ is a unique platform where ground level operational activities are seamlessly linked to project management, providing increased efficiency and speed in running clinical research projects."

"CRO Starter Kit™ is a platform which brings the company together, creating an environment where every action is interconnected with others", says Timur Galimov, Technical Director of Flex Databases. "Such a system becomes self-reinforcing and is much easier to adopt, because it touches a user from multiple angles. One of the big reasons why CTMS implementations fail is because they affect a limited number of users and become just another database, not connected to anything else and not affecting anything else. The experience and industry knowledge of GCT allowed them to avoid this pitfall by selecting Flex CRO Starter Kit™."


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More than 5,000+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Flex Databases Launches New Web Site
New website cements the company's unique positioning as a PSA company.
Tuesday, March 25, 2014
Scientific News
Drug to Treat Alcohol Use Disorder Shows Promise Among Drinkers With High Stress
The findings suggest that potential future studies with drugs targeting vasopressin blockade should focus on populations of people with AUD who also report high levels of stress.
Scientists Find Lethal Vulnerability in Treatment-Resistant Lung Cancer
The study describes how the drug Selinexor killed lung cancer cells and shrank tumors in mice when used against cancers driven by the aggressive and difficult-to-treat KRAS cancer gene.
Advanced Lymphoma in Remission After T-Cell Therapy
63% of trial participants who recieved two-drug combination chemo plus intermediate dose of engineered T cells went into complete remission.
New Treatment for Immune Cancers
Clinical trial shows new drug holds promise for treating advanced mastocytosis.
Sickle Cell Gene Therapy Passes Test
Researchers found a precision-engineered gene therapy virus reduced sickle-induced red-cell damage in mice with sickle cell disease.
Opening Door to Oesophageal Cancer Targeted Treatments
Scientists have discovered that oesophageal cancer can be classified into three different subtypes.
Vitamin C May Boost Leukemia Treatment
Studies show that supplementing an epigenetic cancer drug with vitamin C enhanced the drug's effectiveness.
Inovio Launches Zika Vaccine Trial
Inovio launches Zika vaccine trial in midst of Puerto Rico epidemic to explore early signals of vaccine efficacy.
New Hope for Zika Treatment Found in Large-Scale Screen of Existing Drugs
Johns Hopkins researchers join collaborative group to screen 6,000 existing drugs in hopes of finding treatments for Zika Virus infection
FINCH Filgotinib Phase 3 Program Initiated
Galapagos NV reports the initiation of the FINCH global Phase 3 program in rheumatoid arthritis patient populations.
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!